Related Experiment Video

Updated: Jul 6, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

The crisis in antibiotic resistance

H C Neu1

  • 1College of Physicians & Surgeons, Columbia University, New York, NY 10032.

Science (New York, N.Y.)
|August 21, 1992
PubMed

Insights

Antibiotic resistance is a growing threat due to bacterial adaptation and extensive drug use. New strategies are needed to combat resistant bacteria and preserve antibiotic effectiveness.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Widespread antibiotic synthesis has led to complacency regarding bacterial resistance.
  • Bacteria develop resistance through chromosomal alterations or genetic exchange via plasmids and transposons.
  • Key pathogens like Streptococcus pneumoniae, Staphylococcus, Enterobacteriaceae, and Pseudomonas exhibit resistance to older antibiotics.

Purpose of the Study:

  • To highlight the escalating crisis of antibiotic resistance.
  • To identify the mechanisms driving bacterial resistance.
  • To emphasize the need for new strategies to combat antimicrobial resistance.

Main Methods:

  • Review of existing literature on antibiotic resistance mechanisms.
  • Analysis of the impact of antibiotic usage in community and hospital settings.
  • Identification of key bacterial species exhibiting resistance.

Main Results:

  • Bacteria have evolved resistance to numerous antibiotics through genetic mechanisms.
  • Common respiratory, cutaneous, and systemic infections are increasingly caused by resistant strains.
  • Extensive antibiotic use in healthcare and the community has accelerated resistance.

Conclusions:

  • Urgent adoption of antibiotic control programs is necessary.
  • Enhanced hygiene practices are crucial in limiting the spread of resistant bacteria.
  • Development of novel antimicrobial agents with improved efficacy is essential to address the crisis.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...